Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 14847 total
United Therapeutics heads into its October 28 earnings with a pointed new sell rating from Goldman Sachs, short interest climbing sharply, and options traders rotating toward hedges, a convergence of cautious signals…
RTX Corporation heads into its October 20 results carrying a deepening discount to analyst targets, a stock that has now shed 12% over the past month, and a market that is not yet pressing the short side in any…
UAMY heads into October with short sellers dug in, insiders buying into the dip, and the borrow market barely open. The standout story this week is how crowded the short side remains even as the stock slides. UAMY has…
UMB Financial heads into its October 27 earnings report with short sellers adding exposure, options traders turning more cautious, and two major sell-side desks cutting price targets in the same week. The most striking…
Textron heads into its October 29 earnings with short sellers cutting positions sharply and options markets flipping to one of their most bullish readings of the past year. The clearest shift this week is in short…
Teledyne Technologies heads into its October 21 earnings report with the stock drifting lower, the Street maintaining a constructive bias, and short sellers barely present. The price tells a modest but consistent…
OLN heads into its October 29 earnings date with a sharp contradiction: short sellers added aggressively to positions this week while options traders moved in the opposite direction, cutting put exposure to its lowest…
NOV heads into its October 26 earnings date carrying an awkward combination: short interest rebuilding toward a one-month high, a stock off nearly 10% in a month, and a sector-wide selloff that has dragged peers down…
Morgan Stanley has now lost more than 10% over the past month, falling to $192.76, and the week ending September 30 brought a fresh round of target cuts from the Street just as the Q3 print moves inside two weeks. The…
L3Harris Technologies enters its October 29 earnings date with the most striking shift of the week coming not from short sellers but from options traders, who have turned notably more bullish even as the stock…
EMN enters the final stretch before its November 5 earnings report with a contradictory set of signals: short sellers are retreating while options traders are adding defensively to positions, all against a stock that…
City Holding Company heads into its October 23 quarterly print with short sellers quietly adding exposure and options traders notably more cautious than they were a month ago, a contrast to peers that spent the week in…
Cintas heads into October with a wave of post-earnings analyst upgrades pushing against a stock that has drifted 3% lower over the past month, setting up a quiet but genuine tension between Street conviction and price…
Capital One Financial heads into its October 20 earnings with an unusual split: short sellers are quietly retreating, yet the stock has dropped 8.9% over the past month. The real story this week is in options, where…
Coherent Corp. enters the final day of September with an unusual split: a 3.5% Tuesday bounce that still leaves the stock down 5.9% on the week, while options traders have pushed defensive positioning to its most…
TD closes out September having given back the gains flagged in last week's note, with the stock off 2.2% on the week to CAD 168.83 and the borrow market flashing an unusual spike that sits awkwardly against an…
Teleflex heads into the final week of September caught between a fresh analyst upgrade and a short interest position that has been building steadily for a month. The most newsworthy event this week was B of A…
TJX has recovered 2.3% this week to $133.80, but that rebound sits against a backdrop of analyst downgrades, a sharp drawdown in short interest, and options that remain measured rather than excited, a setup where the…
Synopsys reported its Q4 results on September 30 and the stock closed down 0.6% to $415.09, a muted reaction that leaves the bullish setup from the past two weeks largely intact but still unconfirmed by price. The…
Stryker enters the final day of September with a paradox at its core: the stock is up 1.3% on the week to $278.77, yet analysts have spent the past three weeks slashing price targets. The gap between where the shares…
